FibroGen CEO Thomas Neff's 2019 pay jumps 24% to $11M
FibroGen reports 2019 executive compensation
By ExecPay News
Published: April 23, 2020
FibroGen reported fiscal year 2019 executive compensation information on April 23, 2020.
In 2019, six FibroGen executives received on average a compensation package of $6.1M, a 5% increase compared to previous year.
Average pay of disclosed executives at FibroGen
Thomas B. Neff, Chief Executive Officer, received $11M in total, which increased by 24% compared to 2018. 47% of Neff's compensation, or $5.4M, was in stock awards. Neff also received $5.3M in option awards, $687K in salary, as well as $21K in other compensation.
K. Peony Yu, Chief Medical Officer, received a compensation package of $5.9M, which increased by 29% compared to previous year. 52% of the compensation package, or $3M, was in stock awards.
James A. Schoeneck, Chief Executive Officer, earned $5.2M in 2019.
Elias Kouchakji, Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance, received $5M in 2019.
Christine L. Chung, Senior Vice President, China Operations, earned $4.6M in 2019.
Pat Cotroneo, Chief Financial Officer, received $4.3M in 2019, which increases by 21% compared to 2018.
Related executives
Thomas Neff
FibroGen
Chief Executive Officer
James Schoeneck
FibroGen
Chief Executive Officer
Christine Chung
FibroGen
Senior Vice President, China Operations
Pat Cotroneo
FibroGen
Chief Financial Officer
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
K Yu
FibroGen
Chief Medical Officer
You may also like
Source: SEC filing on April 23, 2020.